Thursday, December 01, 2016 11:48:29 AM
BTW, my LOL on last post was in response to your response to HYPI. Gave me a chuckle.
As to your comments.
The Zoetis and Zivo collaboration, IMO, is NOT validation. That could disappear tomorrow. What it does represent is that Zivo had prior sufficiently tested and proved its algae bioactive works as described for a bovine mastitis model. The data and the market opportunity was sufficient enough to warrant Zoetis working with Zivo and establishing a level of exclusivity. Zoetis informed of the required testing necessary for them to "CONSIDER" a license. Zivo is NOT guaranteed a license once the testing has been completed. And of course the bioactive must continue to perform at clinically significant levels to warrant moving beyond the collaboration.
Personally I expect the required testing to be very positive. However running with the big boys can be good and can be a nightmare. They can move as quickly or as slowly as they want with no concern for Zivo.
Not sure I understand this quote:
This stock moves on air and at the whim of whomever is itchy on a given day.
Always value a company on its fully diluted number. The FD market cap is roughly $33-35 million presently. So what does Zivo has to even justify that valuation ? An algae strain that is in testing. They have identified verticals, today they are in ZERO verticals. The biotech valuation model I use takes into account size of the target market segment, adjusts that number based on completion of each step of the development process and further adjusts for other factors and market capture potential. For where Zivo is right now, the valuation is minimal but can jump quickly because of vertical options, size of vertical and progress.
Your buyout scenario, IMO, that is what I would desire, would force the conversion and exercise of all debt and warrants/options in order for those folks to cash out. That is part why always use FD numbers.
A 50 cents market valuation is closer to $140 million today fully diluted. It would take much more to justify for sure.
Historical moves upward on this stock are usually very swift and short lived followed by long periods of nothingness and downward movement. Excepting those moves that were the result of news, you cannot predict it. I could make it move to 20 cents today if I wanted to .... just because. And there is going to be plenty of overhang on any movement north (you can see it in the current trading .12 has been a wall and another 140K offered right now at that level when already had over 100K trade there - there have been multiple 6 figure offers on the board in the last couple weeks) at all levels because the stock is down or flat literally 90+% of the time. So if you haven't sold on spikes in the past, most of the shareholder base would be at a loss and likely very happy to recoup some of the money on upward movement.
As I said last week, I expect short term news from ZIVO. Actually I expect 2 or 3 PRs. I did not expect the patent news. Twas nice but of no real substantive value at present beyond an opportunity to inform and get your message out.
Amigo Mike
Recent ZIVO News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/26/2024 05:36:56 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/26/2024 12:05:12 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 04/09/2024 03:49:14 PM
- Form SCHEDULE 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/14/2024 01:16:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:45:37 PM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 02/15/2024 01:54:37 PM
- ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study • Business Wire • 02/07/2024 09:54:00 PM
- ZIVO Bioscience Announces Uplisting to OTCQB Market • Business Wire • 01/29/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 09:11:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 10:17:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:05:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:23:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:12:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 02:29:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/22/2023 09:21:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:18:41 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 10/30/2023 05:20:31 PM
- ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens • Business Wire • 10/30/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 12:56:59 PM
- ZIVO Bioscience Announces Reverse Stock Split • Business Wire • 10/26/2023 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/04/2023 09:08:51 PM
- ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference • GlobeNewswire Inc. • 10/03/2023 12:30:00 PM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM